Lobbying activity

Q2

PENN AVENUE PARTNERS for ALKERMES, INC.

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $80,000.00 income

Pharmacy

View → Q2

NAVITUS HEALTH SOLUTIONS for NAVITUS HEALTH SOLUTIONS

2nd Quarter (Apr 1 - June 30) 2026 · Wisconsin · House · Senate

Health Issues, Insurance, Pharmacy, Labor Issues/Antitrust/Workplace

View → Q2

MASON STREET CONSULTING, LLC for CAPITAL RX INC.

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $50,000.00 income

Pharmacy

View → Q2

AMERICAN COLLEGE OF CLINICAL PHARMACY for AMERICAN COLLEGE OF CLINICAL PHARMACY

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Pharmacy, Medicare/Medicaid, Health Issues, Education

View → Q2

HACKENSACK MERIDIAN HEALTH for HACKENSACK MERIDIAN HEALTH

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate

Budget/Appropriations, Science/Technology, Health Issues, Education

View → Q2

PRINTING UNITED ALLIANCE for PRINTING UNITED ALLIANCE

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate

Advertising, Apparel/Clothing Industry/Textiles, Environment/Superfund, Labor Issues/Antitrust/Workplace

View → RR

BROWNSTEIN HYATT FARBER SCHRECK, LLP for ELANCO ANIMAL HEALTH

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia

Tariff (miscellaneous tariff bills), Pharmacy

View → Q2

TAUZIN STRATEGIC NETWORKS for RAZORMETRICS

2nd Quarter (Apr 1 - June 30) 2026 · Texas · House · Senate · $30,000.00 income

Medicare/Medicaid, Pharmacy

View → Q2

DAVE KOLBE CONSULTING for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $30,000.00 income

Pharmacy

View → Q2

MCDERMOTT+ LLC for ALLIANCE FOR RURAL HOSPITAL ACCESS

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $60,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for SAVARA INC.

2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $60,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for REGENXBIO INC.

2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate · $60,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $30,000.00 income

Pharmacy, Trade (domestic/foreign)

View → Q2

LMH STRATEGIC SOLUTIONS for MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $230,000.00 income

Pharmacy, Medicare/Medicaid

View → Q2

LMH STRATEGIC SOLUTIONS for INCYTE CORPORATION

2nd Quarter (Apr 1 - June 30) 2026 · Delaware · House · Senate · $50,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for GLAXOSMITHKLINE LLC

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for BICYCLE THERAPEUTICS

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $150,000.00 income

Health Issues, Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS, PLC

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000.00 income

Pharmacy

View → Q2

LMH STRATEGIC SOLUTIONS for ARDELYX, INC.

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $30,000.00 income

Health Issues, Pharmacy

View → Q2

AEGIS LLC for TRIS PHARMA, INC. AND ITS WHOLLY OWNED SUBSIDIARY ADNEURIS THERAPEUTICS FKA TRIS

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate · $50,000.00 income

Pharmacy

View → Q2

AEGIS LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Health Issues

View → Q2

PANNONE LOPES DEVEREAUX & O'GARA LLC for AMGEN

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $9,000.00 income

Pharmacy

View → Q2

MAD GLOBAL STRATEGY for ADNEURIS THERAPEUTICS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · Senate · $15,000.00 income

Pharmacy

View → RR

BGR GOVERNMENT AFFAIRS for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION

2nd Quarter (Apr 1 - June 30) 2026 · Virginia

Pharmacy

View →